HER2-positive breast cancer is a fast-growing type. Learn about its symptoms, causes, treatment, and prevention options. Early detection and targeted therapy can lead to a cure.

Medically reviewed by Lindsay Cook, PharmD If you have HER2-positive breast cancer, your options for treatment will depend on several factors, such as the stage of cancer (early or metastatic) and ...

If you have early-stage HER2-positive breast cancer, here’s good news: There are more treatment options than ever. They can help you live longer while you enjoy a good quality of life.

The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined the pros and cons of biomarker-based ...

HR-positive/HER2-negative is the most common subtype of breast cancer in women. HR-positive/HER2-negative metastatic breast ...

HER2-negative and HER2-positive are types of breast cancer that share some things in common but have plenty of differences, too. Which kind you have can affect the treatment you get.

Patients with smaller stage 1 human epidermal growth factor receptor 2 (HER2)-positive breast cancer had good outcomes whether or not they received chemotherapy. Outcomes were better, however ...

Like chemotherapy, hormone therapy may be used in combination with targeted therapy to slow the progression of HR-positive and HER2-positive metastatic breast cancer.

One development in HER2-positive breast cancer stood out among the rest in 2021: A trastuzumab-based antibody drug conjugate (ADC) as second-line treatment for advanced disease.

Our reason for that is the knowledge that HER2-positive breast cancer without treatment wants to be an aggressive player. Our means of combating that is typically going to be chemotherapy combined ...

Research presented at the 2014 San Antonio Breast Cancer Symposium shows that high levels of lymphocytes, white blood cells found in the immune system, could help identify women with HER2-positive ...

Healio spoke with Amy Tiersten, MD, professor of medicine with Mount Sinai Hospital, about the treatment landscape in HER2-positive breast cancer.She highlighted FDA approvals, interesting ...